Malaria and Sickle Cell Disease Treatment Market Size Report | 2030
[Research Report] The malaria and sickle cell disease treatment market size was valued at US$ 4,457.15 million in 2022 and is projected to reach US$ 29,179.60 million by 2030; it is estimated to record a CAGR of 26.5% from 2022 to 2030.
Market Insights and Analyst View:
A parasite belonging to the Plasmodium genus causes malaria, a potentially fatal illness. The bite of a female Anopheles mosquito transmits this parasite. It can also be found in some regions of Southeast Asia, Central & South America, and sub-Saharan Africa, where malaria is most likely to occur. Although five Plasmodium species can infect people, Plasmodium falciparum (P. falciparum) and Plasmodium vivax (P. vivax) are the most common causes of malarial illnesses. Certain red blood cell abnormalities have changed throughout time to lessen the severity of malaria. Sickle cell trait is one of these red blood cell diseases, where a person generates both normal and aberrant hemoglobin.
Growth Drivers:
Malaria, one of the acute febrile illnesses, is caused by plasmodium parasites and spreads through the infected female Anopheles mosquitoes. Five parasite species in humans mainly cause malaria, and two of these species—Plasmodium falciparum and P. vivax—are considered the greatest threat to human health. Also, P. falciparum is the deadliest malarial parasite, and it is most widely spread across the African continent. Further, P. vivax is the dominant malarial parasite in most countries outside of sub-Saharan Africa. According to the latest World Malaria Report (WMR) 2020 from the World Health Organization (WHO), 241 million cases of malaria were reported in the world, in comparison to 227 million cases that were logged in 2019. According to the same source, the number of deaths caused due to malaria has an annual rise of 69,000. Approximately two-thirds of these deaths, i.e., 47,000, were caused by disruptions in healthcare services during the COVID-19 outbreak; the remaining one-third of deaths, i.e., 22,000 reflected a recent change in the WHO’s methodology for calculating malaria mortality (irrespective of COVID-19 disruptions).
The WHO African region accounted for a high share of the global burden of malaria. In 2020, ~95% of global cases and ~96% of deaths were reported in Africa due to malaria, and ~80% of the total deaths that were reported were in children aged 5 and below. According to the WHO, four African countries, Nigeria, Tanzania, the Democratic Republic of the Congo, and Mozambique, recorded approximately half of all malaria-related deaths that were reported globally. According to the LANCET Regional Health 2020, African countries had the highest burden of malaria; P. falciparum is a notable cause of the highest mortality rates in children younger than 5, which accounts for ∼77% across the world; in African countries, P. falciparum accounts for ∼96% of total mortalities caused among children by malaria. P. vivax has been a causal agent of 2% (4.5 million) of the total cases of malaria, mainly from Asia. According to WMR 2021, ∼2% of the global burden of malaria was recorded by Southeast Asian countries, where India accounted for 83% of estimated malaria cases and 82% of deaths associated with malaria in 2020.
The treatment plan for sickle cell disease (SCD) can be divided into two categories: maintaining health and treating complications. Sickle cell anemia has genotypic and phenotypic variants that are based on unique mutations in hemoglobin genes. There is a high prevalence of the disease as well as a rise in its severity across the globe. According to the WHO, approximately 5% of the world's population has genes inhibiting hemoglobin diseases such as sickle cell anemia and thalassemia. According to a study on sickle cell disease published in the National Library of Medicine, more than 300,000 babies are born with severe hemoglobin disorders each year; also, 400,000 newborns are expected to have sickle cell disease by 2050. In addition, according to a published report in 2023 by the American Society of Hematology, the estimated number of people suffering from SCD in the US is approximately 70,000–100,000. Thus, the rising prevalence of malaria and sickle cell disease in different regions across the globe boosts the malaria and sickle cell disease treatment market growth.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Malaria and Sickle Cell Disease Treatment Market: Strategic Insights
Market Size Value in US$ 4,457.15 million in 2022 Market Size Value by US$ 29,179.60 million by 2030 Growth rate CAGR of 26.5% from 2022 to 2030 Forecast Period 2022-2030 Base Year 2022
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Malaria and Sickle Cell Disease Treatment Market: Strategic Insights
| Market Size Value in | US$ 4,457.15 million in 2022 |
| Market Size Value by | US$ 29,179.60 million by 2030 |
| Growth rate | CAGR of 26.5% from 2022 to 2030 |
| Forecast Period | 2022-2030 |
| Base Year | 2022 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Report Segmentation and Scope:
The malaria and sickle cell disease treatment market is segmented on the basis of treatment, route of administration, distribution channel, and geography. Based on treatment, the market is divided into malaria and sickle cell disease. In terms of route of administration, the malaria and sickle cell disease treatment market is divided into oral and parenteral. Based on distribution channel, the market is categorized into direct tender, hospital pharmacies, retail pharmacies, online pharmacies, and others. The malaria and sickle cell disease treatment market, based on geography, is segmented into North America (US, Canada, and Mexico), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (Australia, China, Japan, India, South Korea, and Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Africa, Nigeria, Congo, Tanzania, Uganda, Ghana, Kenya, Zambia, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).
Segmental Analysis:
The malaria and sickle cell disease treatment market, by treatment, is divided into malaria and sickle cell disease. In 2022, the malaria segment held a larger market share, and the same segment is estimated to grow at a CAGR of 28.5% from 2022 to 2030. The parasite Plasmodium falciparum predominantly causes malaria. Malaria cannot spread directly from person to person; only an infected mosquito bite can transfer the parasite that enters the bloodstream and travels to the liver. Chloroquine (also called chloroquine phosphate) is an antimalarial drug available in the US by prescription only and is sold under the brand name Aralen, and it is also a generic medicine. Quinine, isolated from the Cinchona bark in 1820, was the first identified antimalarial drug. WHO recommends the RTS, S/AS01 (RTS, S) malaria vaccine to prevent malaria in children. Results from the ongoing pilot program in Ghana, Kenya, and Malawi informed the recommendation for the first malaria vaccine. Four years after the pilots, ~1.5 million children have been reached with their first dose of malaria vaccine since 2019.
By route of administration, the malaria and sickle cell disease treatment market is bifurcated into oral and parenteral. In 2022, the oral segment held a larger market share, and the parenteral segment is estimated to record a faster CAGR during the forecast period. Oral drug delivery is the most ideal and suitable route of drug administration as it offers high patient compliance, non-invasiveness, least sterility constraints, cost-effectiveness, flexibility in the design of dosage form, and ease in the manufacturing process. Benefits such as ease of administration and long-term cost efficiency are the major factors fueling the adoption of oral drugs. Low manufacturing cost of capsules, tablets, and other orally administered drugs propel the malaria and sickle cell disease treatment market growth. A few of the available anti-malarial drugs are quinine, quinidine, chloroquine, amodiaquine, tafenoquine proguanil, chlorproguanil, and artemisinin. The Artemisinin-based combination treatments (ACTs) and the combination therapies are being used for treating uncomplicated malaria caused by the P. falciparum parasite. ACTs are the most effective antimalarial medicines currently available in the market.
Based on distribution channel, the malaria and sickle cell disease treatment market is segmented into direct tender, hospital pharmacies, retail pharmacies, online pharmacies, and others. The direct tender segment held the largest market share in 2022. A tender is an offer to do specific duties or provide items for a fixed amount. In the first step of a tender procedure, contractors will be asked to submit sealed bids for construction or to offer particularly planned services or products within a specific time limit. The e-tendering procedure in India is designed to ensure that work for the government or a specific client is completed in a timely manner. Some places, for example, may have specific procurement regulations that dictate how decisions are made and which tenders are accepted. For instance, the All India Institute of Medical Sciences (AIIMS) invites bids from experienced, reputed, and financially sound companies, agencies, and firms for malaria testing kits and drugs from different healthcare facilities in India. Those who have been in a similar business for the last three years and providing the same service to central/state government/reputed private hospitals or autonomous bodies may send their technical and commercial bids in sealed envelopes.
Regional Analysis:
Based on geography, the malaria and sickle cell disease treatment market is categorized into five key regions—North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa. North America captured a significant share of the global market in 2022. According to the Centers for Disease Control and Prevention (CDC), approximately 2,000 cases of malaria are reported annually in the US, mostly in travelers from other countries and immigrants. Pregnant women and children under 5 years of age are at the highest risk of contracting malaria and developing severe diseases. There is a perpetual risk that malaria transmission can resume in the US due to the endurance of anopheles mosquitoes (vectors) capable of transmitting malaria in the US.
According to the Global Fund data from April 2022, cases and deaths related to malaria grew mainly due to delays in funding and disruptions caused by the COVID-19 pandemic. However, efforts to moderate these impacts have seen progress, as mentioned in the Global Fund report in September 2022. Efforts taken by the US government to control malaria include activities primarily through the US President’s Malaria Initiative (PMI), overseen by the US Global Malaria Coordinator. According to Global Health Policy, US funding for malaria control and research activities was approximately US$ 1 billion in FY 2022. The US government’s goal under the PMI Strategy 2021–2026 is to work and reduce deaths caused by malaria and decrease malaria morbidity, in turn approaching its long-term goal of elimination.
In the US, a large number of African-American individuals are suffering from sickle cell disease. Since 2006, all US states have mandated newborn screening for SCD using a blood test. According to the study "Rate of sickle cell disease-related death appears higher during the COVID-19 pandemic" by the CDC, SCD-related death rates were stable in the US during 2014–2019; but the country recorded 1,023 SCD-related mortalities in 2020, registering an upsurge by 12% as compared to the death rate during 2014–2019. According to the data published in 2023 by the American Society of Hematology, ~70,000–100,000 Americans have sickle cell disease, which is the most common form of an inherited blood disorder. Thus, the malaria and sickle cell disease treatment market growth in the US is driven by the rising number of malaria and SCD patients.
Malaria and Sickle Cell Disease Treatment Market Report Scope
Industry Developments and Future Opportunities:
Various initiatives taken by key players operating in the global malaria and sickle cell disease treatment market are listed below:
- In November 2022, Novartis and Medicines for Malaria Venture (MMV) announced decision to move to Phase 3 study for novel non-artemisinin combination to treat uncomplicated malaria. This novel combination also contains an optimized formulation of lumefantrine, which allows it to be given once daily versus the usual twice-daily administration.
- In October 2022, Pfizer Inc acquired Global Blood Therapeutics Inc. GBT brings a portfolio and pipeline that has the potential to address the full spectrum of critical needs for this underserved community. GBT discovered and developed Oxbryta (voxelotor), a first-in-class medicine that directly targets the root cause of SCD.
Competitive Landscape and Key Companies:
Cipla Ltd, Pfizer Inc, Sun Pharmaceutical Industries Ltd, Sanofi SA, GSK Plc, Novartis AG, Pfizer Inc, Emmaus Life Sciences Inc, AdvaCare Pharma USA LLC, VLP Therapeutics LLC, and Lupin Ltd are among the major malaria and sickle cell disease treatment companies. These companies focus on new technologies, advancements in existing products, and geographic expansions to meet the growing consumer demand worldwide.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Treatment, Route of Administration, and Distribution Channel
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Based on route of administration, the oral segment took the forefront leaders in the worldwide market by accounting largest share in 2022 and is expected to continue to do so till the forecast period.
Malaria and sickle cell disease treatment market is segmented by countries comprising of North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America.
The originators segment dominated the sickle cell disease treatment market and accounted for the largest market share in 2022. However, the vaccine segment dominated the malaria treatment market and accounted for the largest market share in 2022.
Malaria is a serious infection spread by an infected mosquito. The infection is very common in certain parts of the world, such as large areas of Africa and Asia, Central and South America, and the Dominican Republic and Haiti. However, malaria is an entirely preventable and treatable disease if tackled at an early stage. For example, malaria is treated with a prescription drug to kill the parasite. The types of drugs and the length of treatment vary depending on the type of malarial parasite infection, the severity of symptoms, and age.
Sickle cell disease (SCD) is the most common inherited blood disorder that affects the red blood cells. Treatments for SCD can relieve pain and help prevent complications related with the disease. SCD is identified with a simple blood test. In addition, SCD can be detected while the baby is in the womb. Diagnostic tests such as amniocentesis and chorionic villus sampling are done before the baby is born, which helps to check the chromosomal or genetic abnormalities in the baby. A bone marrow transplant can cure SCD. The transplant needs a donor who’s healthy, genetic match, such as a sibling. However, only about 18% of people with SCD have a compatible donor. In addition, there are complications and risks involved with a transplant.
The direct tender segment dominated the malaria treatment market and accounted for the largest market share in 2022.
Cipla Ltd, Pfizer Inc, Sun Pharmaceutical Industries Ltd, Sanofi SA, GSK Plc, Novartis AG, Pfizer Inc, Emmaus Life Sciences Inc, AdvaCare Pharma USA LLC, VLP Therapeutics LLC, and Lupin Ltd among others are among the leading companies operating in the malaria and sickle cell disease treatment market.
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights - Malaria
2.2 Key Insights – Sickle Cell Disease
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Malaria and Sickle Cell Disease Treatment Market Landscape
4.1 Overview
4.2 PEST Analysis – Malaria Treatment
4.3 PEST Analysis – Sickle Cell Disease Treatment
5. Malaria and Sickle Cell Disease Treatment Market - Key Industry Dynamics
5.1 Key Market Drivers:
5.1.1 Increasing Prevalence of Malaria and Sickle Cell Disease
5.1.2 Rising Initiatives to Raise Awareness about Malaria and SCD
5.2 Market Restraints
5.2.1 Lack of Sickle Cell Disease Treatment Options and Availability of Counterfeit Antimalarial Drugs Followed by Subsequent Drug Resistance
5.3 Market Opportunities
5.3.1 Growing Strategic Initiatives by Market Players
5.4 Future Trends
5.4.1 Extending Pipeline of New Drugs and Vaccines
5.5 Impact Analysis
6. Malaria and Sickle Cell Disease Treatment Market - Global Market Analysis
6.1 Malaria Treatment Market Revenue (US$ million), 2022 – 2030
6.2 Sickle Cell Disease Treatment Market Revenue (US$ million), 2022 – 2030
6.3 Geography Analysis Market Revenue (US$ million), 2022 – 2030
6.4 Epidemiology Data for Malaria
6.4.1 Malaria Transmission Characteristics, Immunity, and Clinical Features
6.4.2 Estimated Malaria Cases and Deaths
6.4.2.1 Fundings for Malaria-Related R&D, 2021
6.4.2.2 Fundings for Malaria Control, 2021
6.5 Funding Allocation Mechanism
6.5.1 Global Funds
6.5.1.1 USAID: Burundi-Malaria Operational Plan FY 2022
6.5.1.2 Procurement Scenario For Malaria Drugs
6.6 Reimbursement Scenario for Malaria
6.6.1 Overview
6.7 Sickle Cell Disease
6.7.1.1 Epidemiology Data of Sickle Cell Disease (SCD), 2020
6.8 Fundings for Sickle Cell Disease (SCD)
6.9 Reimbursement Scenario for Sickle Cell Disease
6.9.1 Overview
6.10 Number of Healthcare Facilities and Healthcare Expenditure:
7. Malaria and Sickle Cell Disease Treatment Market – Revenue and Forecast to 2030 – by Treatment
7.1 Overview
7.2 Malaria Treatment Market Revenue Share, by Treatment 2022 & 2030 (%)
7.3 Overview
7.4 Sickle Cell Disease Treatment Market Revenue Share, by Treatment 2022 & 2030 (%)
7.5 Malaria
7.5.1 Overview
7.5.2 Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
7.5.2.1 Malaria Treatment Market, by Treatment
7.6 Sickle Cell Disease (SCD)
7.6.1 Overview
7.6.2 Sickle Cell Disease Treatment Market – Revenue and Forecast to 2030 (US$ Million)
7.6.2.1 Sickle Cell Disease Treatment Market, by Treatment
8. Malaria and Sickle Cell Disease Treatment Market – Revenue and Forecast to 2030 – by Route of Administration
8.1 Overview
8.2 Malaria Treatment Market Revenue Share, by Route of Administration 2022 & 2030 (%)
8.3 Overview
8.4 Sickle Cell Disease Treatment Market Revenue Share, by Route of Administration 2022 & 2030 (%)
8.5 Oral
8.5.1 Overview
8.5.2 Oral: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
8.5.3 Oral: Sickle Cell Disease Treatment Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Parenteral
8.6.1 Overview
8.6.2 Parenteral: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
8.6.3 Parenteral: Sickle Cell Disease Treatment Market – Revenue and Forecast to 2030 (US$ Million)
9. Malaria and Sickle Cell Disease Treatment Market – Revenue and Forecast to 2030 – by Distribution Channel
9.1 Overview
9.2 Malaria Treatment Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
9.3 Overview
9.4 Sickle Cell Disease Treatment Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
9.5 Direct Tender
9.5.1 Overview
9.5.2 Direct Tender: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
9.5.3 Direct Tender: Sickle Cell Disease Treatment Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Hospital Pharmacies
9.6.1 Overview
9.6.2 Hospital Pharmacies: Malaria Market – Revenue and Forecast to 2030 (US$ Million)
9.6.2.1.1 Malaria Treatment Market, by Hospital Pharmacies
9.6.3 Hospital Pharmacies: Sickle Cell Disease Treatment Market – Revenue and Forecast to 2030 (US$ Million)
9.6.3.1.1 Sickle Cell Disease Treatment Market, by Hospital Pharmacies
9.7 Retail Pharmacies
9.7.1 Overview
9.7.2 Retail Pharmacies: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
9.7.2.1.1 Malaria Treatment Market, by Retail Pharmacies
9.7.3 Retail Pharmacies: Sickle Cell Disease Treatment Market – Revenue and Forecast to 2030 (US$ Million)
9.7.3.1.1 Sickle Cell Disease Treatment Market, by Retail Pharmacies
9.8 Online Pharmacies
9.8.1 Overview
9.8.2 Online Pharmacies: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
9.8.3 Online Pharmacies: Sickle Cell Disease Treatment Market – Revenue and Forecast to 2030 (US$ Million)
9.9 Others
9.9.1 Overview
9.9.2 Others : Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
9.9.3 Others: Sickle Cell Disease Treatment Market – Revenue and Forecast to 2030 (US$ Million)
10. Malaria and Sickle Cell Disease Treatment Market - Geographical Analysis
10.1 North America Malaria and Sickle Cell Disease Treatment Market, Revenue and Forecast To 2030
10.1.1 Overview
10.1.2 Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.1.3 Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.1.3.1 North America: Malaria Treatment Market, by Treatment
10.1.3.2 North America: Sickle Cell Disease Treatment Market, by Treatment
10.1.3.3 North America: Malaria Treatment Market, by Route of Administration
10.1.3.4 North America: Sickle Cell Disease Treatment Market, by Route of Administration
10.1.3.5 North America: Malaria Treatment Market, by Distribution Channel
10.1.3.5.1 North America: Malaria Treatment Market, by Hospital Pharmacies
10.1.3.5.2 North America: Malaria Treatment Market, by Retail Pharmacies
10.1.3.6 North America: Sickle Cell Treatment Market, by Distribution Channel
10.1.3.6.1 North America: Sickle Cell Treatment Market, by Hospital Pharmacies
10.1.3.6.2 North America: Sickle Cell Treatment Market, by Retail Pharmacies
10.1.3.7 North America: Malaria Treatment Market, by Country
10.1.3.8 North America: Sickle Cell Disease Treatment Market, by Country
10.1.3.9 US
10.1.3.10 Overview
10.1.3.10.1 US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.1.3.10.2 US: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.1.3.10.3 US: Malaria Treatment Market, by Treatment
10.1.3.10.4 US: Sickle Cell Disease Treatment Market, by Treatment
10.1.3.10.5 US: Malaria -Malaria Treatment Market, by Route of Administration
10.1.3.10.6 US: Sickle Cell Disease Treatment Market, by Route of Administration
10.1.3.10.7 US: Malaria Treatment Market, by Distribution Channel
10.1.3.10.7.1 US: Malaria Treatment Market, by Hospital Pharmacies
10.1.3.10.7.2 US: Malaria Treatment Market, by Retail Pharmacies
10.1.3.10.8 US: Sickle Cell Disease Treatment Market, by Distribution Channel
10.1.3.10.8.1 US: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.1.3.10.8.2 US: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.1.3.11 Canada
10.1.3.12 Overview
10.1.3.12.1 Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.1.3.12.2 Canada: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.1.3.12.3 Canada: Malaria Treatment Market, by Treatment
10.1.3.12.4 Canada: Sickle Cell Disease Treatment Market, by Treatment
10.1.3.12.5 Canada: Malaria -Malaria Treatment Market, by Route of Administration
10.1.3.12.6 Canada: Sickle Cell Disease Treatment Market, by Route of Administration
10.1.3.12.7 Canada: Malaria Treatment Market, by Distribution Channel
10.1.3.12.7.1 Canada: Malaria Treatment Market, by Hospital Pharmacies
10.1.3.12.7.2 Canada: Malaria Treatment Market, by Retail Pharmacies
10.1.3.12.8 Canada: Sickle Cell Disease Treatment Market, by Distribution Channel
10.1.3.12.8.1 Canada: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.1.3.12.8.2 Canada: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.1.3.13 Mexico
10.1.3.14 Overview
10.1.3.14.1 Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.1.3.14.2 Mexico: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.1.3.14.3 Mexico: Malaria Treatment Market, by Treatment
10.1.3.14.4 Mexico: Sickle Cell Disease Treatment Market, by Treatment
10.1.3.14.5 Mexico: Malaria -Malaria Treatment Market, by Route of Administration
10.1.3.14.6 Mexico: Sickle Cell Disease Treatment Market, by Route of Administration
10.1.3.14.7 Mexico: Malaria Treatment Market, by Distribution Channel
10.1.3.14.7.1 Mexico: Malaria Treatment Market, by Hospital Pharmacies
10.1.3.14.7.2 Mexico: Malaria Treatment Market, by Retail Pharmacies
10.1.3.14.8 Mexico: Sickle Cell Disease Treatment Market, by Distribution Channel
10.1.3.14.8.1 Mexico: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.1.3.14.8.2 Mexico: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.2 Europe Malaria and Sickle Cell Disease Treatment Market, Revenue and Forecast To 2030
10.2.1 Overview
10.2.2 Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.2.3 Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.2.3.1 Europe: Malaria Treatment Market, by Treatment
10.2.3.2 Europe: Sickle Cell Disease Treatment Market, by Treatment
10.2.3.3 Europe: Malaria Treatment Market, by Route of Administration
10.2.3.4 Europe: Sickle Cell Disease Treatment Market, by Route of Administration
10.2.3.5 Europe: Malaria Treatment Market, by Distribution Channel
10.2.3.5.1 Europe: Malaria Treatment Market, by Hospital Pharmacies
10.2.3.5.2 Europe: Malaria Treatment Market, by Retail Pharmacies
10.2.3.6 Europe: Sickle Cell Treatment Market, by Distribution Channel
10.2.3.6.1 Europe: Sickle Cell Treatment Market, by Hospital Pharmacies
10.2.3.6.2 Europe: Sickle Cell Treatment Market, by Retail Pharmacies
10.2.3.7 Europe: Malaria Treatment Market, by Countries
10.2.3.8 Europe: Sickle Cell Disease Treatment Market, by Countries
10.2.3.9 France
10.2.3.10 Overview
10.2.3.10.1 France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.2.3.10.2 France: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.2.3.10.3 France: Malaria Treatment Market, by Treatment
10.2.3.10.4 France: Sickle Cell Disease Treatment Market, by Treatment
10.2.3.10.5 France: Malaria -Malaria Treatment Market, by Route of Administration
10.2.3.10.6 France: Sickle Cell Disease Treatment Market, by Route of Administration
10.2.3.10.7 France: Malaria Treatment Market, by Distribution Channel
10.2.3.10.7.1 France: Malaria Treatment Market, by Hospital Pharmacies
10.2.3.10.7.2 France: Malaria Treatment Market, by Retail Pharmacies
10.2.3.10.8 France: Sickle Cell Disease Treatment Market, by Distribution Channel
10.2.3.10.8.1 France: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.2.3.10.8.2 France: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.2.3.11 UK
10.2.3.12 Overview
10.2.3.12.1 UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.2.3.12.2 UK: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.2.3.12.3 UK: Malaria Treatment Market, by Treatment
10.2.3.12.4 UK: Sickle Cell Disease Treatment Market, by Treatment
10.2.3.12.5 UK: Malaria -Malaria Treatment Market, by Route of Administration
10.2.3.12.6 UK: Sickle Cell Disease Treatment Market, by Route of Administration
10.2.3.12.7 UK: Malaria Treatment Market, by Distribution Channel
10.2.3.12.7.1 UK: Malaria Treatment Market, by Hospital Pharmacies
10.2.3.12.7.2 UK: Malaria Treatment Market, by Retail Pharmacies
10.2.3.12.8 UK: Sickle Cell Disease Treatment Market, by Distribution Channel
10.2.3.12.8.1 UK: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.2.3.12.8.2 UK: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.2.3.13 Italy
10.2.3.14 Overview
10.2.3.14.1 Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.2.3.14.2 Italy: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.2.3.14.3 Italy: Malaria Treatment Market, by Treatment
10.2.3.14.4 Italy: Sickle Cell Disease Treatment Market, by Treatment
10.2.3.14.5 Italy: Malaria -Malaria Treatment Market, by Route of Administration
10.2.3.14.6 Italy: Sickle Cell Disease Treatment Market, by Route of Administration
10.2.3.14.7 Italy: Malaria Treatment Market, by Distribution Channel
10.2.3.14.7.1 Italy: Malaria Treatment Market, by Hospital Pharmacies
10.2.3.14.7.2 Italy: Malaria Treatment Market, by Retail Pharmacies
10.2.3.14.8 Italy: Sickle Cell Disease Treatment Market, by Distribution Channel
10.2.3.14.8.1 Italy: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.2.3.14.8.2 Italy: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.2.3.15 Germany
10.2.3.16 Overview
10.2.3.16.1 Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.2.3.16.2 Germany: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.2.3.16.3 Germany: Malaria Treatment Market, by Treatment
10.2.3.16.4 Germany: Sickle Cell Disease Treatment Market, by Treatment
10.2.3.16.5 Germany: Malaria -Malaria Treatment Market, by Route of Administration
10.2.3.16.6 Germany: Sickle Cell Disease Treatment Market, by Route of Administration
10.2.3.16.7 Germany: Malaria Treatment Market, by Distribution Channel
10.2.3.16.7.1 Germany: Malaria Treatment Market, by Hospital Pharmacies
10.2.3.16.7.2 Germany: Malaria Treatment Market, by Retail Pharmacies
10.2.3.16.8 Germany: Sickle Cell Disease Treatment Market, by Distribution Channel
10.2.3.16.8.1 Germany: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.2.3.16.8.2 Germany: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.2.3.17 Spain
10.2.3.18 Overview
10.2.3.18.1 Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.2.3.18.2 Spain: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.2.3.18.3 Spain: Malaria Treatment Market, by Treatment
10.2.3.18.4 Spain: Sickle Cell Disease Treatment Market, by Treatment
10.2.3.18.5 Spain: Malaria -Malaria Treatment Market, by Route of Administration
10.2.3.18.6 Spain: Sickle Cell Disease Treatment Market, by Route of Administration
10.2.3.18.7 Spain: Malaria Treatment Market, by Distribution Channel
10.2.3.18.7.1 Spain: Malaria Treatment Market, by Hospital Pharmacies
10.2.3.18.7.2 Spain: Malaria Treatment Market, by Retail Pharmacies
10.2.3.18.8 Spain: Sickle Cell Disease Treatment Market, by Distribution Channel
10.2.3.18.8.1 Spain: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.2.3.18.8.2 Spain: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.2.3.19 Rest of Europe
10.2.3.20 Overview
10.2.3.20.1 Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.2.3.20.2 Rest of Europe: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.2.3.20.3 Rest of Europe: Malaria Treatment Market, by Treatment
10.2.3.20.4 Rest of Europe: Sickle Cell Disease Treatment Market, by Treatment
10.2.3.20.5 Rest of Europe: Malaria -Malaria Treatment Market, by Route of Administration
10.2.3.20.6 Rest of Europe: Sickle Cell Disease Treatment Market, by Route of Administration
10.2.3.20.7 Rest of Europe: Malaria Treatment Market, by Distribution Channel
10.2.3.20.7.1 Rest of Europe: Malaria Treatment Market, by Hospital Pharmacies
10.2.3.20.7.2 Rest of Europe: Malaria Treatment Market, by Retail Pharmacies
10.2.3.20.8 Rest of Europe: Sickle Cell Disease Treatment Market, by Distribution Channel
10.2.3.20.8.1 Rest of Europe: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.2.3.20.8.2 Rest of Europe: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.3 Asia Pacific Malaria and Sickle Cell Disease Treatment Market, Revenue and Forecast To 2030
10.3.1 Overview
10.3.2 Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.3.3 Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.3.3.1 Asia Pacific: Malaria Treatment Market, by Treatment
10.3.3.2 Asia Pacific: Sickle Cell Disease Treatment Market, by Treatment
10.3.3.3 Asia Pacific: Malaria Treatment Market, by Route of Administration
10.3.3.4 Asia Pacific: Sickle Cell Disease Treatment Market, by Route of Administration
10.3.3.5 Asia Pacific: Malaria Treatment Market, by Distribution Channel
10.3.3.5.1 Asia Pacific: Malaria Treatment Market, by Hospital Pharmacies
10.3.3.5.2 Asia Pacific: Malaria Treatment Market, by Retail Pharmacies
10.3.3.6 Asia Pacific: Sickle Cell Treatment Market, by Distribution Channel
10.3.3.6.1 Asia Pacific: Sickle Cell Treatment Market, by Hospital Pharmacies
10.3.3.6.2 Asia Pacific: Sickle Cell Treatment Market, by Retail Pharmacies
10.3.3.7 Asia Pacific: Malaria Treatment Market, by Countries
10.3.3.8 Asia Pacific: Sickle Cell Disease Treatment Market, by Country
10.3.3.9 China
10.3.3.10 Overview
10.3.3.10.1 China: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.3.3.10.2 China: Sickle Cell Disease Treatment Market, by Treatment
10.3.3.10.3 China: Sickle Cell Disease Treatment Market, by Route of Administration
10.3.3.10.4 China: Sickle Cell Disease Treatment Market, by Distribution Channel
10.3.3.10.4.1 China: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.3.3.10.4.2 China: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.3.3.11 Japan
10.3.3.12 Overview
10.3.3.12.1 Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.3.3.12.2 Japan: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.3.3.12.3 Japan: Malaria Treatment Market, by Treatment
10.3.3.12.4 Japan: Sickle Cell Disease Treatment Market, by Treatment
10.3.3.12.5 Japan: Malaria -Malaria Treatment Market, by Route of Administration
10.3.3.12.6 Japan: Sickle Cell Disease Treatment Market, by Route of Administration
10.3.3.12.7 Japan: Malaria Treatment Market, by Distribution Channel
10.3.3.12.7.1 Japan: Malaria Treatment Market, by Hospital Pharmacies
10.3.3.12.7.2 Japan: Malaria Treatment Market, by Retail Pharmacies
10.3.3.12.8 Japan: Sickle Cell Disease Treatment Market, by Distribution Channel
10.3.3.12.8.1 Japan: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.3.3.12.8.2 Japan: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.3.3.13 India
10.3.3.14 Overview
10.3.3.14.1 India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.3.3.14.2 India: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.3.3.14.3 India: Malaria Treatment Market, by Treatment
10.3.3.14.4 India: Sickle Cell Disease Treatment Market, by Treatment
10.3.3.14.5 India: Malaria -Malaria Treatment Market, by Route of Administration
10.3.3.14.6 India: Sickle Cell Disease Treatment Market, by Route of Administration
10.3.3.14.7 India: Malaria Treatment Market, by Distribution Channel
10.3.3.14.7.1 India: Malaria Treatment Market, by Hospital Pharmacies
10.3.3.14.7.2 India: Malaria Treatment Market, by Retail Pharmacies
10.3.3.14.8 India: Sickle Cell Disease Treatment Market, by Distribution Channel
10.3.3.14.8.1 India: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.3.3.14.8.2 India: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.3.3.15 South Korea
10.3.3.16 Overview
10.3.3.16.1 South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.3.3.16.2 South Korea: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.3.3.16.3 South Korea: Malaria Treatment Market, by Treatment
10.3.3.16.4 South Korea: Sickle Cell Disease Treatment Market, by Treatment
10.3.3.16.5 South Korea: Malaria -Malaria Treatment Market, by Route of Administration
10.3.3.16.6 South Korea: Sickle Cell Disease Treatment Market, by Route of Administration
10.3.3.16.7 South Korea: Malaria Treatment Market, by Distribution Channel
10.3.3.16.7.1 South Korea: Malaria Treatment Market, by Hospital Pharmacies
10.3.3.16.7.2 South Korea: Malaria Treatment Market, by Retail Pharmacies
10.3.3.16.8 South Korea: Sickle Cell Disease Treatment Market, by Distribution Channel
10.3.3.16.8.1 South Korea: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.3.3.16.8.2 South Korea: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.3.3.17 Australia
10.3.3.18 Overview
10.3.3.18.1 Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.3.3.18.2 Australia: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.3.3.18.3 Australia: Malaria Treatment Market, by Treatment
10.3.3.18.4 Australia: Sickle Cell Disease Treatment Market, by Treatment
10.3.3.18.5 Australia: Malaria -Malaria Treatment Market, by Route of Administration
10.3.3.18.6 Australia: Sickle Cell Disease Treatment Market, by Route of Administration
10.3.3.18.7 Australia: Malaria Treatment Market, by Distribution Channel
10.3.3.18.7.1 Australia: Malaria Treatment Market, by Hospital Pharmacies
10.3.3.18.7.2 Australia: Malaria Treatment Market, by Retail Pharmacies
10.3.3.18.8 Australia: Sickle Cell Disease Treatment Market, by Distribution Channel
10.3.3.18.8.1 Australia: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.3.3.18.8.2 Australia: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.3.3.19 Rest of Asia Pacific
10.3.3.20 Overview
10.3.3.20.1 Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.3.3.20.2 Rest of Asia Pacific: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.3.3.20.3 Rest of Asia Pacific: Malaria Treatment Market, by Treatment
10.3.3.20.4 Rest of Asia Pacific: Sickle Cell Disease Treatment Market, by Treatment
10.3.3.20.5 Rest of Asia Pacific: Malaria -Malaria Treatment Market, by Route of Administration
10.3.3.20.6 Rest of Asia Pacific: Sickle Cell Disease Treatment Market, by Route of Administration
10.3.3.20.7 Rest of Asia Pacific: Malaria Treatment Market, by Distribution Channel
10.3.3.20.7.1 Rest of Asia Pacific: Malaria Treatment Market, by Hospital Pharmacies
10.3.3.20.7.2 Rest of Asia Pacific: Malaria Treatment Market, by Retail Pharmacies
10.3.3.20.8 Rest of Asia Pacific: Sickle Cell Disease Treatment Market, by Distribution Channel
10.3.3.20.8.1 Rest of Asia Pacific: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.3.3.20.8.2 Rest of Asia Pacific: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.4 Middle East & Africa Malaria and Sickle Cell Disease Treatment Market, Revenue and Forecast To 2030
10.4.1 Overview
10.4.2 Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3 Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3.1 Middle East & Africa: Malaria Treatment Market, by Treatment
10.4.3.2 Middle East & Africa: Sickle Cell Disease Treatment Market, by Treatment
10.4.3.3 Middle East & Africa: Malaria Treatment Market, by Route of Administration
10.4.3.4 Middle East & Africa: Sickle Cell Disease Treatment Market, by Route of Administration
10.4.3.5 Middle East & Africa: Malaria Treatment Market, by Distribution Channel
10.4.3.5.1 Middle East & Africa: Malaria Treatment Market, by Hospital Pharmacies
10.4.3.5.2 Middle East & Africa: Malaria Treatment Market, by Retail Pharmacies
10.4.3.6 Middle East & Africa: Sickle Cell Treatment Market, by Distribution Channel
10.4.3.6.1 Middle East & Africa: Sickle Cell Treatment Market, by Hospital Pharmacies
10.4.3.6.2 Middle East & Africa: Sickle Cell Treatment Market, by Retail Pharmacies
10.4.3.7 Middle East & Africa: Malaria Treatment Market, by Country
10.4.3.8 Middle East & Africa: Sickle Cell Disease Treatment Market, by Country
10.4.3.9 Saudi Arabia
10.4.3.10 Overview
10.4.3.10.1 Saudi Arabia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3.10.2 Saudi Arabia: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3.10.3 Saudi Arabia: Malaria Treatment Market, by Treatment
10.4.3.10.4 Saudi Arabia: Sickle Cell Disease Treatment Market, by Treatment
10.4.3.10.5 Saudi Arabia: Malaria -Malaria Treatment Market, by Route of Administration
10.4.3.10.6 Saudi Arabia: Sickle Cell Disease Treatment Market, by Route of Administration
10.4.3.10.7 Saudi Arabia: Malaria Treatment Market, by Distribution Channel
10.4.3.10.7.1 Saudi Arabia: Malaria Treatment Market, by Hospital Pharmacies
10.4.3.10.7.2 Saudi Arabia: Malaria Treatment Market, by Retail Pharmacies
10.4.3.10.8 Saudi Arabia: Sickle Cell Disease Treatment Market, by Distribution Channel
10.4.3.10.8.1 Saudi Arabia: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.4.3.10.8.2 Saudi Arabia: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.4.3.11 UAE
10.4.3.12 Overview
10.4.3.12.1 UAE: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3.12.2 UAE: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3.12.3 UAE: Malaria Treatment Market, by Treatment
10.4.3.12.4 UAE: Sickle Cell Disease Treatment Market, by Treatment
10.4.3.12.5 UAE: Malaria -Malaria Treatment Market, by Route of Administration
10.4.3.12.6 UAE: Sickle Cell Disease Treatment Market, by Route of Administration
10.4.3.12.7 UAE: Malaria Treatment Market, by Distribution Channel
10.4.3.12.7.1 UAE: Malaria Treatment Market, by Hospital Pharmacies
10.4.3.12.7.2 UAE: Malaria Treatment Market, by Retail Pharmacies
10.4.3.12.8 UAE: Sickle Cell Disease Treatment Market, by Distribution Channel
10.4.3.12.8.1 UAE: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.4.3.12.8.2 UAE: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.4.3.13 South Africa
10.4.3.14 Overview
10.4.3.14.1 South Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3.14.2 South Africa: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3.14.3 South Africa: Malaria Treatment Market, by Treatment
10.4.3.14.4 South Africa: Sickle Cell Disease Treatment Market, by Treatment
10.4.3.14.5 South Africa: Malaria -Malaria Treatment Market, by Route of Administration
10.4.3.14.6 South Africa: Sickle Cell Disease Treatment Market, by Route of Administration
10.4.3.14.7 South Africa: Malaria Treatment Market, by Distribution Channel
10.4.3.14.7.1 South Africa: Malaria Treatment Market, by Hospital Pharmacies
10.4.3.14.7.2 South Africa: Malaria Treatment Market, by Retail Pharmacies
10.4.3.14.8 South Africa: Sickle Cell Disease Treatment Market, by Distribution Channel
10.4.3.14.8.1 South Africa: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.4.3.14.8.2 South Africa: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.4.3.15 Kenya
10.4.3.16 Overview
10.4.3.16.1 Kenya: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3.16.2 Kenya: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3.16.3 Kenya: Malaria Treatment Market, by Treatment
10.4.3.16.4 Kenya: Sickle Cell Disease Treatment Market, by Treatment
10.4.3.16.5 Kenya: Malaria -Malaria Treatment Market, by Route of Administration
10.4.3.16.6 Kenya: Sickle Cell Disease Treatment Market, by Route of Administration
10.4.3.16.7 Kenya: Malaria Treatment Market, by Distribution Channel
10.4.3.16.7.1 Kenya: Malaria Treatment Market, by Hospital Pharmacies
10.4.3.16.7.2 Kenya: Malaria Treatment Market, by Retail Pharmacies
10.4.3.16.8 Kenya: Sickle Cell Disease Treatment Market, by Distribution Channel
10.4.3.16.8.1 Kenya: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.4.3.16.8.2 Kenya: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.4.3.17 Tanzania
10.4.3.18 Overview
10.4.3.18.1 Tanzania: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3.18.2 Tanzania: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3.18.3 Tanzania: Malaria Treatment Market, by Treatment
10.4.3.18.4 Tanzania: Sickle Cell Disease Treatment Market, by Treatment
10.4.3.18.5 Tanzania: Malaria -Malaria Treatment Market, by Route of Administration
10.4.3.18.6 Tanzania: Sickle Cell Disease Treatment Market, by Route of Administration
10.4.3.18.7 Tanzania: Malaria Treatment Market, by Distribution Channel
10.4.3.18.7.1 Tanzania: Malaria Treatment Market, by Hospital Pharmacies
10.4.3.18.7.2 Tanzania: Malaria Treatment Market, by Retail Pharmacies
10.4.3.18.8 Tanzania: Sickle Cell Disease Treatment Market, by Distribution Channel
10.4.3.18.8.1 Tanzania: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.4.3.18.8.2 Tanzania: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.4.3.19 Rwanda
10.4.3.20 Overview
10.4.3.20.1 Rwanda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3.20.2 Rwanda: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3.20.3 Rwanda: Malaria Treatment Market, by Treatment
10.4.3.20.4 Rwanda: Sickle Cell Disease Treatment Market, by Treatment
10.4.3.20.5 Rwanda: Malaria -Malaria Treatment Market, by Route of Administration
10.4.3.20.6 Rwanda: Sickle Cell Disease Treatment Market, by Route of Administration
10.4.3.20.7 Rwanda: Malaria Treatment Market, by Distribution Channel
10.4.3.20.7.1 Rwanda: Malaria Treatment Market, by Hospital Pharmacies
10.4.3.20.7.2 Rwanda: Malaria Treatment Market, by Retail Pharmacies
10.4.3.20.8 Rwanda: Sickle Cell Disease Treatment Market, by Distribution Channel
10.4.3.20.8.1 Rwanda: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.4.3.20.8.2 Rwanda: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.4.3.21 Nigeria
10.4.3.22 Overview
10.4.3.22.1 Nigeria: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3.22.2 Nigeria: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3.22.3 Nigeria: Malaria Treatment Market, by Treatment
10.4.3.22.4 Nigeria: Sickle Cell Disease Treatment Market, by Treatment
10.4.3.22.5 Nigeria: Malaria -Malaria Treatment Market, by Route of Administration
10.4.3.22.6 Nigeria: Sickle Cell Disease Treatment Market, by Route of Administration
10.4.3.22.7 Nigeria: Malaria Treatment Market, by Distribution Channel
10.4.3.22.7.1 Nigeria: Malaria Treatment Market, by Hospital Pharmacies
10.4.3.22.7.2 Nigeria: Malaria Treatment Market, by Retail Pharmacies
10.4.3.22.8 Nigeria: Sickle Cell Disease Treatment Market, by Distribution Channel
10.4.3.22.8.1 Nigeria: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.4.3.22.8.2 Nigeria: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.4.3.23 Ghana
10.4.3.24 Overview
10.4.3.24.1 Ghana: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3.24.2 Ghana: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3.24.3 Ghana: Malaria Treatment Market, by Treatment
10.4.3.24.4 Ghana: Sickle Cell Disease Treatment Market, by Treatment
10.4.3.24.5 Ghana: Malaria -Malaria Treatment Market, by Route of Administration
10.4.3.24.6 Ghana: Sickle Cell Disease Treatment Market, by Route of Administration
10.4.3.24.7 Ghana: Malaria Treatment Market, by Distribution Channel
10.4.3.24.7.1 Ghana: Malaria Treatment Market, by Hospital Pharmacies
10.4.3.24.7.2 Ghana: Malaria Treatment Market, by Retail Pharmacies
10.4.3.24.8 Ghana: Sickle Cell Disease Treatment Market, by Distribution Channel
10.4.3.24.8.1 Ghana: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.4.3.24.8.2 Ghana: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.4.3.25 Uganda
10.4.3.26 Overview
10.4.3.26.1 Uganda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3.26.2 Uganda: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3.26.3 Uganda: Malaria Treatment Market, by Treatment
10.4.3.26.4 Uganda: Sickle Cell Disease Treatment Market, by Treatment
10.4.3.26.5 Uganda: Malaria -Malaria Treatment Market, by Route of Administration
10.4.3.26.6 Uganda: Sickle Cell Disease Treatment Market, by Route of Administration
10.4.3.26.7 Uganda: Malaria Treatment Market, by Distribution Channel
10.4.3.26.7.1 Uganda: Malaria Treatment Market, by Hospital Pharmacies
10.4.3.26.7.2 Uganda: Malaria Treatment Market, by Retail Pharmacies
10.4.3.26.8 Uganda: Sickle Cell Disease Treatment Market, by Distribution Channel
10.4.3.26.8.1 Uganda: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.4.3.26.8.2 Uganda: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.4.3.27 Angola
10.4.3.28 Overview
10.4.3.28.1 Angola: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3.28.2 Angola: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3.28.3 Angola: Malaria Treatment Market, by Treatment
10.4.3.28.4 Angola: Sickle Cell Disease Treatment Market, by Treatment
10.4.3.28.5 Angola: Malaria -Malaria Treatment Market, by Route of Administration
10.4.3.28.6 Angola: Sickle Cell Disease Treatment Market, by Route of Administration
10.4.3.28.7 Angola: Malaria Treatment Market, by Distribution Channel
10.4.3.28.7.1 Angola: Malaria Treatment Market, by Hospital Pharmacies
10.4.3.28.7.2 Angola: Malaria Treatment Market, by Retail Pharmacies
10.4.3.28.8 Angola: Sickle Cell Disease Treatment Market, by Distribution Channel
10.4.3.28.8.1 Angola: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.4.3.28.8.2 Angola: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.4.3.29 Cameroon
10.4.3.30 Overview
10.4.3.30.1 Cameroon: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3.30.2 Cameroon: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3.30.3 Cameroon: Malaria Treatment Market, by Treatment
10.4.3.30.4 Cameroon: Sickle Cell Disease Treatment Market, by Treatment
10.4.3.30.5 Cameroon: Malaria -Malaria Treatment Market, by Route of Administration
10.4.3.30.6 Cameroon: Sickle Cell Disease Treatment Market, by Route of Administration
10.4.3.30.7 Cameroon: Malaria Treatment Market, by Distribution Channel
10.4.3.30.7.1 Cameroon: Malaria Treatment Market, by Hospital Pharmacies
10.4.3.30.7.2 Cameroon: Malaria Treatment Market, by Retail Pharmacies
10.4.3.30.8 Cameroon: Sickle Cell Disease Treatment Market, by Distribution Channel
10.4.3.30.8.1 Cameroon: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.4.3.30.8.2 Cameroon: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.4.3.31 Senegal
10.4.3.32 Overview
10.4.3.32.1 Senegal: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3.32.2 Senegal: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3.32.3 Senegal: Malaria Treatment Market, by Treatment
10.4.3.32.4 Senegal: Sickle Cell Disease Treatment Market, by Treatment
10.4.3.32.5 Senegal: Malaria -Malaria Treatment Market, by Route of Administration
10.4.3.32.6 Senegal: Sickle Cell Disease Treatment Market, by Route of Administration
10.4.3.32.7 Senegal: Malaria Treatment Market, by Distribution Channel
10.4.3.32.7.1 Senegal: Malaria Treatment Market, by Hospital Pharmacies
10.4.3.32.7.2 Senegal: Malaria Treatment Market, by Retail Pharmacies
10.4.3.32.8 Senegal: Sickle Cell Disease Treatment Market, by Distribution Channel
10.4.3.32.8.1 Senegal: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.4.3.32.8.2 Senegal: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.4.3.33 Zambia
10.4.3.34 Overview
10.4.3.34.1 Zambia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3.34.2 Zambia: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3.34.3 Zambia: Malaria Treatment Market, by Treatment
10.4.3.34.4 Zambia: Sickle Cell Disease Treatment Market, by Treatment
10.4.3.34.5 Zambia: Malaria -Malaria Treatment Market, by Route of Administration
10.4.3.34.6 Zambia: Sickle Cell Disease Treatment Market, by Route of Administration
10.4.3.34.7 Zambia: Malaria Treatment Market, by Distribution Channel
10.4.3.34.7.1 Zambia: Malaria Treatment Market, by Hospital Pharmacies
10.4.3.34.7.2 Zambia: Malaria Treatment Market, by Retail Pharmacies
10.4.3.34.8 Zambia: Sickle Cell Disease Treatment Market, by Distribution Channel
10.4.3.34.8.1 Zambia: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.4.3.34.8.2 Zambia: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.4.3.35 Rest of Middle East & Africa
10.4.3.36 Overview
10.4.3.36.1 Rest of Middle East & Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3.36.2 Rest of Middle East & Africa: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.4.3.36.3 Rest of Middle East & Africa: Malaria Treatment Market, by Treatment
10.4.3.36.4 Rest of Middle East & Africa: Sickle Cell Disease Treatment Market, by Treatment
10.4.3.36.5 Rest of Middle East & Africa: Malaria -Malaria Treatment Market, by Route of Administration
10.4.3.36.6 Rest of Middle East & Africa: Sickle Cell Disease Treatment Market, by Route of Administration
10.4.3.36.7 Rest of Middle East & Africa: Malaria Treatment Market, by Distribution Channel
10.4.3.36.7.1 Rest of Middle East & Africa: Malaria Treatment Market, by Hospital Pharmacies
10.4.3.36.7.2 Rest of Middle East & Africa: Malaria Treatment Market, by Retail Pharmacies
10.4.3.36.8 Rest of Middle East & Africa: Sickle Cell Disease Treatment Market, by Distribution Channel
10.4.3.36.8.1 Rest of Middle East & Africa: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.4.3.36.8.2 Rest of Middle East & Africa: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.5 Asia Pacific Malaria and Sickle Cell Disease Treatment Market, Revenue and Forecast To 2030
10.5.1 Overview
10.5.2 Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.5.3 Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.5.3.1 Asia Pacific: Malaria Treatment Market, by Treatment
10.5.3.2 Asia Pacific: Sickle Cell Disease Treatment Market, by Treatment
10.5.3.3 Asia Pacific: Malaria Treatment Market, by Route of Administration
10.5.3.4 Asia Pacific: Sickle Cell Disease Treatment Market, by Route of Administration
10.5.3.5 Asia Pacific: Malaria Treatment Market, by Distribution Channel
10.5.3.5.1 Asia Pacific: Malaria Treatment Market, by Hospital Pharmacies
10.5.3.5.2 Asia Pacific: Malaria Treatment Market, by Retail Pharmacies
10.5.3.6 Asia Pacific: Sickle Cell Treatment Market, by Distribution Channel
10.5.3.6.1 Asia Pacific: Sickle Cell Treatment Market, by Hospital Pharmacies
10.5.3.6.2 Asia Pacific: Sickle Cell Treatment Market, by Retail Pharmacies
10.5.3.7 Asia Pacific: Malaria Treatment Market, by Countries
10.5.3.8 Asia Pacific: Sickle Cell Disease Treatment Market, by Country
10.5.3.9 China
10.5.3.10 Overview
10.5.3.10.1 China: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.5.3.10.2 China: Sickle Cell Disease Treatment Market, by Treatment
10.5.3.10.3 China: Sickle Cell Disease Treatment Market, by Route of Administration
10.5.3.10.4 China: Sickle Cell Disease Treatment Market, by Distribution Channel
10.5.3.10.4.1 China: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.5.3.10.4.2 China: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.5.3.11 Japan
10.5.3.12 Overview
10.5.3.12.1 Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.5.3.12.2 Japan: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.5.3.12.3 Japan: Malaria Treatment Market, by Treatment
10.5.3.12.4 Japan: Sickle Cell Disease Treatment Market, by Treatment
10.5.3.12.5 Japan: Malaria -Malaria Treatment Market, by Route of Administration
10.5.3.12.6 Japan: Sickle Cell Disease Treatment Market, by Route of Administration
10.5.3.12.7 Japan: Malaria Treatment Market, by Distribution Channel
10.5.3.12.7.1 Japan: Malaria Treatment Market, by Hospital Pharmacies
10.5.3.12.7.2 Japan: Malaria Treatment Market, by Retail Pharmacies
10.5.3.12.8 Japan: Sickle Cell Disease Treatment Market, by Distribution Channel
10.5.3.12.8.1 Japan: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.5.3.12.8.2 Japan: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.5.3.13 India
10.5.3.14 Overview
10.5.3.14.1 India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.5.3.14.2 India: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.5.3.14.3 India: Malaria Treatment Market, by Treatment
10.5.3.14.4 India: Sickle Cell Disease Treatment Market, by Treatment
10.5.3.14.5 India: Malaria -Malaria Treatment Market, by Route of Administration
10.5.3.14.6 India: Sickle Cell Disease Treatment Market, by Route of Administration
10.5.3.14.7 India: Malaria Treatment Market, by Distribution Channel
10.5.3.14.7.1 India: Malaria Treatment Market, by Hospital Pharmacies
10.5.3.14.7.2 India: Malaria Treatment Market, by Retail Pharmacies
10.5.3.14.8 India: Sickle Cell Disease Treatment Market, by Distribution Channel
10.5.3.14.8.1 India: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.5.3.14.8.2 India: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.5.3.15 South Korea
10.5.3.16 Overview
10.5.3.16.1 South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.5.3.16.2 South Korea: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.5.3.16.3 South Korea: Malaria Treatment Market, by Treatment
10.5.3.16.4 South Korea: Sickle Cell Disease Treatment Market, by Treatment
10.5.3.16.5 South Korea: Malaria -Malaria Treatment Market, by Route of Administration
10.5.3.16.6 South Korea: Sickle Cell Disease Treatment Market, by Route of Administration
10.5.3.16.7 South Korea: Malaria Treatment Market, by Distribution Channel
10.5.3.16.7.1 South Korea: Malaria Treatment Market, by Hospital Pharmacies
10.5.3.16.7.2 South Korea: Malaria Treatment Market, by Retail Pharmacies
10.5.3.16.8 South Korea: Sickle Cell Disease Treatment Market, by Distribution Channel
10.5.3.16.8.1 South Korea: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.5.3.16.8.2 South Korea: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.5.3.17 Australia
10.5.3.18 Overview
10.5.3.18.1 Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.5.3.18.2 Australia: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.5.3.18.3 Australia: Malaria Treatment Market, by Treatment
10.5.3.18.4 Australia: Sickle Cell Disease Treatment Market, by Treatment
10.5.3.18.5 Australia: Malaria -Malaria Treatment Market, by Route of Administration
10.5.3.18.6 Australia: Sickle Cell Disease Treatment Market, by Route of Administration
10.5.3.18.7 Australia: Malaria Treatment Market, by Distribution Channel
10.5.3.18.7.1 Australia: Malaria Treatment Market, by Hospital Pharmacies
10.5.3.18.7.2 Australia: Malaria Treatment Market, by Retail Pharmacies
10.5.3.18.8 Australia: Sickle Cell Disease Treatment Market, by Distribution Channel
10.5.3.18.8.1 Australia: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.5.3.18.8.2 Australia: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.5.3.19 Rest of Asia Pacific
10.5.3.20 Overview
10.5.3.20.1 Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.5.3.20.2 Rest of Asia Pacific: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.5.3.20.3 Rest of Asia Pacific: Malaria Treatment Market, by Treatment
10.5.3.20.4 Rest of Asia Pacific: Sickle Cell Disease Treatment Market, by Treatment
10.5.3.20.5 Rest of Asia Pacific: Malaria -Malaria Treatment Market, by Route of Administration
10.5.3.20.6 Rest of Asia Pacific: Sickle Cell Disease Treatment Market, by Route of Administration
10.5.3.20.7 Rest of Asia Pacific: Malaria Treatment Market, by Distribution Channel
10.5.3.20.7.1 Rest of Asia Pacific: Malaria Treatment Market, by Hospital Pharmacies
10.5.3.20.7.2 Rest of Asia Pacific: Malaria Treatment Market, by Retail Pharmacies
10.5.3.20.8 Rest of Asia Pacific: Sickle Cell Disease Treatment Market, by Distribution Channel
10.5.3.20.8.1 Rest of Asia Pacific: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.5.3.20.8.2 Rest of Asia Pacific: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.6 South & Central America Malaria and Sickle Cell Disease Treatment Market, Revenue and Forecast To 2030
10.6.1 Overview
10.6.2 Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.6.3 Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.6.3.1 South & Central America: Malaria Treatment Market, by Treatment
10.6.3.2 South & Central America: Sickle Cell Disease Treatment Market, by Treatment
10.6.3.3 South & Central America: Malaria Treatment Market, by Route of Administration
10.6.3.4 South & Central America: Sickle Cell Disease Treatment Market, by Route of Administration
10.6.3.5 South & Central America: Malaria Treatment Market, by Distribution Channel
10.6.3.5.1 South & Central America: Malaria Treatment Market, by Hospital Pharmacies
10.6.3.5.2 South & Central America: Malaria Treatment Market, by Retail Pharmacies
10.6.3.6 South & Central America: Sickle Cell Treatment Market, by Distribution Channel
10.6.3.6.1 South & Central America: Sickle Cell Treatment Market, by Hospital Pharmacies
10.6.3.6.2 South & Central America: Sickle Cell Treatment Market, by Retail Pharmacies
10.6.3.7 South & Central America: Malaria Treatment Market, by Countries
10.6.3.8 South & Central America: Sickle Cell Disease Treatment Market, by Countries
10.6.3.9 Brazil
10.6.3.10 Overview
10.6.3.10.1 Brazil: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.6.3.10.2 Brazil: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.6.3.10.3 Brazil: Malaria Treatment Market, by Treatment
10.6.3.10.4 Brazil: Sickle Cell Disease Treatment Market, by Treatment
10.6.3.10.5 Brazil: Malaria -Malaria Treatment Market, by Route of Administration
10.6.3.10.6 Brazil: Sickle Cell Disease Treatment Market, by Route of Administration
10.6.3.10.7 Brazil: Malaria Treatment Market, by Distribution Channel
10.6.3.10.7.1 Brazil: Malaria Treatment Market, by Hospital Pharmacies
10.6.3.10.7.2 Brazil: Malaria Treatment Market, by Retail Pharmacies
10.6.3.10.8 Brazil: Sickle Cell Disease Treatment Market, by Distribution Channel
10.6.3.10.8.1 Brazil: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.6.3.10.8.2 Brazil: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.6.3.11 Argentina
10.6.3.12 Overview
10.6.3.12.1 Argentina: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.6.3.12.2 Argentina: Sickle Cell Disease Treatment Market, by Treatment
10.6.3.12.3 Argentina: Sickle Cell Disease Treatment Market, by Route of Administration
10.6.3.12.4 Argentina: Sickle Cell Disease Treatment Market, by Distribution Channel
10.6.3.12.4.1 Argentina: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.6.3.12.4.2 Argentina: Sickle Cell Disease Treatment Market, by Retail Pharmacies
10.6.3.13 Rest of South & Central America
10.6.3.14 Overview
10.6.3.14.1 Rest of South & Central America: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.6.3.14.2 Rest of South & Central America: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.6.3.14.3 Rest of South & Central America: Malaria Treatment Market, by Treatment
10.6.3.14.4 Rest of South & Central America: Sickle Cell Disease Treatment Market, by Treatment
10.6.3.14.5 Rest of South & Central America: Malaria -Malaria Treatment Market, by Route of Administration
10.6.3.14.6 Rest of South & Central America: Sickle Cell Disease Treatment Market, by Route of Administration
10.6.3.14.7 Rest of South & Central America: Malaria Treatment Market, by Distribution Channel
10.6.3.14.7.1 Rest of South & Central America: Malaria Treatment Market, by Hospital Pharmacies
10.6.3.14.7.2 Rest of South & Central America: Malaria Treatment Market, by Retail Pharmacies
10.6.3.14.8 Rest of South & Central America: Sickle Cell Disease Treatment Market, by Distribution Channel
10.6.3.14.8.1 Rest of South & Central America: Sickle Cell Disease Treatment Market, by Hospital Pharmacies
10.6.3.14.8.2 Rest of South & Central America: Sickle Cell Disease Treatment Market, by Retail Pharmacies
11. Malaria and Sickle Cell Disease Treatment Market Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Malaria and Sickle Cell Disease Treatment Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 1.1 Cipla Ltd
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Sun Pharmaceutical Industries Ltd
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Sanofi SA
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 GSK Plc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Novartis AG
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Pfizer Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Service
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Emmaus Life Sciences Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 AdvaCare Pharma USA LLC
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 VLP Therapeutics LLC
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Lupin Ltd
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
12.11 Teva Pharmaceutical Industries Ltd
12.11.1 Key Facts
12.11.2 Business Description
12.11.3 Products and Services
12.11.4 Financial Overview
12.11.5 SWOT Analysis
12.11.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms
14. Appendix
List of Tables
Table 1. Malaria and Sickle Cell Disease Treatment Market Segmentation
Table 2. Malaria Drugs/Vaccine/Compounds Under Clinical Development
Table 3. Sickle Cell Disease Drugs/Vaccine/Compounds Under Clinical Development
Table 4. Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 5. Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 6. Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Hospital Pharmacies
Table 7. Sickle Cell Disease Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Hospital Pharmacies
Table 8. Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Retail Pharmacies
Table 9. Sickle Cell Disease Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Retail Pharmacies
Table 10. North America: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 11. North America: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 12. North America: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Route of Administration
Table 13. North America: Sickle Cell Disease Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Route of Administration
Table 14. North America: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Distribution Channel
Table 15. North America: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Hospital Pharmacies
Table 16. North America: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Hospital Pharmacies
Table 17. North America: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Distribution Channel
Table 18. North America: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Hospital Pharmacies
Table 19. North America: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Retail Pharmacies
Table 20. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 21. US: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 22. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 23. US: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 24. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 25. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 26. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 27. US: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 28. US: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 29. US: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 30. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 31. Canada: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 32. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 33. Canada: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 34. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 35. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 36. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 37. Canada: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 38. Canada: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 39. Canada: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 40. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 41. Mexico: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 42. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 43. Mexico: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 44. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 45. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 46. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 47. Mexico: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 48. Mexico: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 49. Mexico: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 50. Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 51. Europe: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 52. Europe: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Route of Administration
Table 53. Europe: Sickle Cell Disease Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Route of Administration
Table 54. Europe: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Distribution Channel
Table 55. Europe: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Hospital Pharmacies
Table 56. Europe: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Hospital Pharmacies
Table 57. Europe: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Distribution Channel
Table 58. Europe: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Hospital Pharmacies
Table 59. Europe: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Retail Pharmacies
Table 60. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 61. France: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 62. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 63. France: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 64. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 65. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 66. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 67. France: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 68. France: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 69. France: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 70. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 71. UK: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 72. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 73. UK: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 74. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 75. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 76. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 77. UK: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 78. UK: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 79. UK: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 80. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 81. Italy: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 82. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 83. Italy: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 84. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 85. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 86. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 87. Italy: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 88. Italy: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 89. Italy: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 90. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 91. Germany: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 92. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 93. Germany: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 94. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 95. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 96. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 97. Germany: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 98. Germany: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 99. Germany: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 100. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 101. Spain: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 102. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 103. Spain: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 104. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 105. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 106. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 107. Spain: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 108. Spain: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 109. Spain: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 110. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 111. Rest of Europe: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 112. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 113. Rest of Europe: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 114. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 115. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 116. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 117. Rest of Europe: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 118. Rest of Europe: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 119. Rest of Europe: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 120. Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 121. Asia Pacific: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 122. Asia Pacific: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Route of Administration
Table 123. Asia Pacific: Sickle Cell Disease Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Route of Administration
Table 124. Asia Pacific: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Distribution Channel
Table 125. Asia Pacific: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Hospital Pharmacies
Table 126. Asia Pacific: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Hospital Pharmacies
Table 127. Asia Pacific: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Distribution Channel
Table 128. Asia Pacific: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Hospital Pharmacies
Table 129. Asia Pacific: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Retail Pharmacies
Table 130. China: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 131. China: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 132. China: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 133. China: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 134. China: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 135. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 136. Japan: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 137. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 138. Japan: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 139. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 140. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 141. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 142. Japan: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 143. Japan: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 144. Japan: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 145. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 146. India: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 147. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 148. India: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 149. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 150. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 151. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 152. India: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 153. India: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 154. India: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 155. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 156. South Korea: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 157. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 158. South Korea: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 159. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 160. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 161. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 162. South Korea: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 163. South Korea: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 164. South Korea: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 165. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 166. Australia: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 167. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 168. Australia: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 169. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 170. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 171. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 172. Australia: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 173. Australia: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 174. Australia: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 175. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 176. Rest of Asia Pacific: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 177. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 178. Rest of Asia Pacific: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 179. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 180. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 181. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 182. Rest of Asia Pacific: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 183. Rest of Asia Pacific: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 184. Rest of Asia Pacific: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 185. Middle East & Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 186. Middle East & Africa: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 187. Middle East & Africa: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Route of Administration
Table 188. Middle East & Africa: Sickle Cell Disease Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Route of Administration
Table 189. Middle East & Africa: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Distribution Channel
Table 190. Middle East & Africa: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Hospital Pharmacies
Table 191. Middle East & Africa: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Hospital Pharmacies
Table 192. Middle East & Africa: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Distribution Channel
Table 193. Middle East & Africa: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Hospital Pharmacies
Table 194. Middle East & Africa: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Retail Pharmacies
Table 195. Saudi Arabia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 196. Saudi Arabia: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 197. Saudi Arabia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 198. Saudi Arabia: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 199. Saudi Arabia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 200. Saudi Arabia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 201. Saudi Arabia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 202. Saudi Arabia: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 203. Saudi Arabia: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 204. Saudi Arabia: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 205. UAE: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 206. UAE: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 207. UAE: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 208. UAE: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 209. UAE: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 210. UAE: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 211. UAE: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 212. UAE: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 213. UAE: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 214. UAE: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 215. South Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 216. South Africa: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 217. South Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 218. South Africa: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 219. South Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 220. South Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 221. South Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 222. South Africa: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 223. South Africa: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 224. South Africa: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 225. Kenya: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 226. Kenya: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 227. Kenya: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 228. Kenya: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 229. Kenya: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 230. Kenya: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 231. Kenya: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 232. Kenya: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 233. Kenya: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 234. Kenya: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 235. Tanzania: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 236. Tanzania: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 237. Tanzania: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 238. Tanzania: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 239. Tanzania: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 240. Tanzania: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 241. Tanzania: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 242. Tanzania: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 243. Tanzania: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 244. Tanzania: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 245. Rwanda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 246. Rwanda: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 247. Rwanda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 248. Rwanda: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 249. Rwanda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 250. Rwanda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 251. Rwanda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 252. Rwanda: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 253. Rwanda: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 254. Rwanda: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 255. Nigeria Malaria Treatment Market, by Treatment – Revenue and Forecast to 2030 (USD Million)
Table 256. Nigeria: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 257. Nigeria: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 258. Nigeria: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 259. Nigeria: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 260. Nigeria: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 261. Nigeria: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 262. Nigeria: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 263. Nigeria: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 264. Nigeria: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 265. Ghana: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 266. Ghana: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 267. Ghana: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 268. Ghana: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 269. Ghana: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 270. Ghana: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 271. Ghana: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 272. Ghana: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 273. Ghana: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 274. Ghana: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 275. Uganda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 276. Uganda: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 277. Uganda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 278. Uganda: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 279. Uganda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 280. Uganda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 281. Uganda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 282. Uganda: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 283. Uganda: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 284. Uganda: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 285. Angola: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 286. Angola: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 287. Angola: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 288. Angola: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 289. Angola: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 290. Angola: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 291. Angola: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 292. Angola: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 293. Angola: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 294. Angola: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 295. Cameroon: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 296. Cameroon: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 297. Cameroon: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 298. Cameroon: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 299. Cameroon: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 300. Cameroon: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 301. Cameroon: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 302. Cameroon: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 303. Cameroon: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 304. Cameroon: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 305. Senegal: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 306. Senegal: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 307. Senegal: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 308. Senegal: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 309. Senegal: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 310. Senegal: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 311. Senegal: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 312. Senegal: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 313. Senegal: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 314. Senegal: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 315. Zambia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 316. Zambia: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 317. Zambia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 318. Zambia: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 319. Zambia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 320. Zambia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 321. Zambia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 322. Zambia: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 323. Zambia: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 324. Zambia: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 325. Rest of Middle East & Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 326. Rest of Middle East & Africa: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 327. Rest of Middle East & Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 328. Rest of Middle East & Africa: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 329. Rest of Middle East & Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 330. Rest of Middle East & Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 331. Rest of Middle East & Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 332. Rest of Middle East & Africa: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 333. Rest of Middle East & Africa: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 334. Rest of Middle East & Africa: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 335. Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 336. Asia Pacific: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 337. Asia Pacific: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Route of Administration
Table 338. Asia Pacific: Sickle Cell Disease Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Route of Administration
Table 339. Asia Pacific: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Distribution Channel
Table 340. Asia Pacific: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Hospital Pharmacies
Table 341. Asia Pacific: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Hospital Pharmacies
Table 342. Asia Pacific: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Distribution Channel
Table 343. Asia Pacific: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Hospital Pharmacies
Table 344. Asia Pacific: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Retail Pharmacies
Table 345. China: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 346. China: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 347. China: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 348. China: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 349. China: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 350. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 351. Japan: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 352. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 353. Japan: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 354. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 355. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 356. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 357. Japan: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 358. Japan: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 359. Japan: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 360. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 361. India: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 362. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 363. India: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 364. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 365. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 366. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 367. India: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 368. India: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 369. India: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 370. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 371. South Korea: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 372. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 373. South Korea: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 374. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 375. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 376. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 377. South Korea: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 378. South Korea: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 379. South Korea: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 380. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 381. Australia: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 382. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 383. Australia: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 384. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 385. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 386. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 387. Australia: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 388. Australia: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 389. Australia: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 390. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 391. Rest of Asia Pacific: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 392. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 393. Rest of Asia Pacific: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 394. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 395. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 396. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 397. Rest of Asia Pacific: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 398. Rest of Asia Pacific: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 399. Rest of Asia Pacific: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 400. South & Central America: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 401. South & Central America: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 402. South & Central America: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Route of Administration
Table 403. South & Central America: Sickle Cell Disease Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Route of Administration
Table 404. South & Central America: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Distribution Channel
Table 405. South & Central America: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Hospital Pharmacies
Table 406. South & Central America: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Hospital Pharmacies
Table 407. South & Central America: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Distribution Channel
Table 408. South & Central America: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Hospital Pharmacies
Table 409. South & Central America: Malaria Treatment Market Revenue and Forecast To 2030 (US$ Mn) – Retail Pharmacies
Table 410. Brazil: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 411. Brazil: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 412. Brazil: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 413. Brazil: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 414. Brazil: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 415. Brazil: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 416. Brazil: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 417. Brazil: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 418. Brazil: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 419. Brazil: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 420. Argentina: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 421. Argentina: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 422. Argentina: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 423. Argentina: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 424. Argentina: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 425. Rest of South & Central America: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 426. Rest of South & Central America: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Treatment
Table 427. Rest of South & Central America: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 428. Rest of South & Central America: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Route of Administration
Table 429. Rest of South & Central America: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 430. Rest of South & Central America: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 431. Rest of South & Central America: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Retail Pharmacies
Table 432. Rest of South & Central America: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 433. Rest of South & Central America: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Hospital Pharmacies
Table 434. Rest of South & Central America: Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn) – Distribution Channel
Table 435. Recent Inorganic Growth Strategies in the Malaria and Sickle Cell Disease Treatment Market
Table 436. Recent Organic Growth Strategies in the Malaria and Sickle Cell Disease Treatment Market
Table 437. Glossary of Terms, Malaria and Sickle Cell Disease Treatment Market
List of Figures
Figure 1. PEST Analysis - Malaria
Figure 2. PEST Analysis - Sickle Cell Disease Treatment
Figure 3. Malaria and Sickle Cell Disease Treatment Market - Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Malaria Treatment Market Revenue (US$ million), 2020 – 2030
Figure 6. Sickle Cell Disease Treatment Market Revenue (US$ million), 2020 – 2030
Figure 7. Malaria: Geography Analysis Market Revenue (US$ million), 2022 – 2030
Figure 8. Sickle Cell Disease: Geography Analysis Market Revenue (US$ million), 2022 – 2030
Figure 9. Malaria Treatment Market Revenue Share, by Treatment 2022 & 2030 (%)
Figure 10. Sickle Cell Disease Treatment Market Revenue Share, by Treatment 2022 & 2030 (%)
Figure 11. Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Sickle Cell Disease Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Malaria Treatment Market Revenue Share, by Route of Administration 2022 & 2030 (%)
Figure 14. Sickle Cell Disease Market Revenue Share, by Route of Administration 2022 & 2030 (%)
Figure 15. Oral: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Oral: Sickle Cell Disease Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Parenteral: Malaria and Sickle Cell Disease Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Parenteral: Sickle Cell Disease Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Malaria Treatment Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
Figure 20. Sickle Cell Disease Treatment Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
Figure 21. Direct Tender: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Direct Tender: Sickle Cell Disease Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Hospital Pharmacies: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. Hospital Pharmacies: Sickle Cell Disease Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. Retail Pharmacies: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 26. Retail Pharmacies: Sickle Cell Disease Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. Online Pharmacies: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 28. Online Pharmacies: Sickle Cell Disease Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 29. Online Pharmacies: Malaria Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 30. Others: Sickle Cell Disease Treatment Market – Revenue and Forecast to 2030 (US$ Million)
Figure 31. North America Malaria Treatment Market, By Geography, 2022 ($Mn)
Figure 32. North America Sickle Cell Disease Treatment Market, By Geography, 2022 ($Mn)
Figure 33. Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 34. Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 35. North America: Malaria Treatment Market, By Key Countries, 2022 And 2030 (%)
Figure 36. North America: Sickle Cell Disease Treatment Market, By Key Countries, 2022 And 2030 (%)
Figure 37. US: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 38. US: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 39. Canada: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 40. Canada: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 41. Mexico: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 42. Mexico: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 43. Europe Malaria Treatment Market, By Geography, 2022 ($Mn)
Figure 44. Europe Malaria and Sickle Cell Disease Treatment Market, By Geography, 2022 ($Mn)
Figure 45. Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 46. Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 47. Europe: Malaria Treatment Market, By Key Countries, 2022 And 2030 (%)
Figure 48. Europe: Sickle Cell Disease Treatment Market, By Key Countries, 2022 And 2030 (%)
Figure 49. France: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 50. France: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 51. UK: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 52. UK: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 53. Italy: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 54. Italy: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 55. Germany: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 56. Germany: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 57. Spain: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 58. Spain: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 59. Rest of Europe: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 60. Rest of Europe: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 61. Malaria Treatment Market, 2022 ($Mn)
Figure 62. Sickle Cell Disease Treatment Market, 2022 ($Mn)
Figure 63. Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 64. Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 65. Asia Pacific: Malaria Treatment Market, By Key Countries, 2022 And 2030 (%)
Figure 66. Asia Pacific: Sickle Cell Disease Treatment Market, By Key Countries, 2022 And 2030 (%)
Figure 67. China: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 68. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 69. Japan: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 70. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 71. India: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 72. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 73. South Korea: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 74. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 75. Australia: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 76. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 77. Rest of Asia Pacific: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 78. Malaria Treatment Market, 2022 (US$ Mn)
Figure 79. Sickle Cell Disease Treatment Market, 2022 (US$ Mn)
Figure 80. Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 81. Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 82. Middle East & Africa: Malaria Treatment Market, By Key Countries, 2022 And 2030 (%)
Figure 83. Middle East & Africa: Sickle Cell Disease Treatment Market, By Key Countries, 2022 And 2030 (%)
Figure 84. Saudi Arabia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 85. Saudi Arabia: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 86. UAE: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 87. UAE: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 88. South Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 89. South Africa: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 90. Kenya: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 91. Kenya: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 92. Tanzania: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 93. Tanzania: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 94. Rwanda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 95. Rwanda: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 96. Nigeria: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 97. Nigeria: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 98. Ghana: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 99. Ghana: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 100. Uganda: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 101. Uganda: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 102. Angola: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 103. Angola: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 104. Cameroon: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 105. Cameroon: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 106. Senegal: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 107. Senegal: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 108. Zambia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 109. Zambia: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 110. Rest of Middle East & Africa: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 111. Rest of Middle East & Africa: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 112. Malaria Treatment Market, 2022 ($Mn)
Figure 113. Sickle Cell Disease Treatment Market, 2022 ($Mn)
Figure 114. Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 115. Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 116. Asia Pacific: Malaria Treatment Market, By Key Countries, 2022 And 2030 (%)
Figure 117. Asia Pacific: Sickle Cell Disease Treatment Market, By Key Countries, 2022 And 2030 (%)
Figure 118. China: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 119. Japan: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 120. Japan: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 121. India: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 122. India: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 123. South Korea: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 124. South Korea: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 125. Australia: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 126. Australia: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 127. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 128. Rest of Asia Pacific: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 129. Malaria Treatment Market, 2022 ($Mn)
Figure 130. Sickle Cell Disease Treatment Market, 2022 ($Mn)
Figure 131. Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 132. Sickle Cell Disease Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 133. South & Central America: Malaria Treatment Market, By Key Countries, 2022 And 2030 (%)
Figure 134. South & Central America: Sickle Cell Disease Treatment Market, By Key Countries, 2022 And 2030 (%)
Figure 135. Brazil: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 136. Brazil: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 137. Argentina: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 138. Rest of South & Central America: Malaria Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 139. Rest of South & Central America: Sickle Cell Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 140. Growth Strategies in the Malaria and Sickle Cell Disease Treatment Market
The List of Companies - Malaria and Sickle Cell Disease Treatment Market
- Cipla Ltd
- Pfizer Inc
- Sun Pharmaceutical Industries Ltd
- Sanofi SA
- GSK Plc
- Novartis AG
- Pfizer Inc
- Emmaus Life Sciences Inc
- AdvaCare Pharma USA LLC
- VLP Therapeutics LLC
- Lupin Ltd
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For